By definition, the monochromat requires only one primary in order to match the entire visible spectrum. As we will see, many of those who are labelled as 'monochromats' do display a crude form of residual colour discrimination when tested under specific conditions. This has two unfortunate consequences. The first is that it gives rise to misnomers such as 'incomplete achromatopsia'. The second is that, because there is no recognised standard for assessing such subjects, two independent laboratories using different testing apparatus may differ in the diagnosis of identical conditions. Monochromats may be subdivided according to the type of photoreceptor(s) they retain. The distinction between some forms of monochromatism is unclear, and clarification will have to await the discovery of the underlying genetic mutations.
we would direct the reader to several reviews published on the subject. [3] [4] [5] [6] Monochromatism By definition, the monochromat requires only one primary in order to match the entire visible spectrum. As we will see, many of those who are labelled as 'monochromats' do display a crude form of residual colour discrimination when tested under specific conditions. This has two unfortunate consequences. The first is that it gives rise to misnomers such as 'incomplete achromatopsia'. The second is that, because there is no recognised standard for assessing such subjects, two independent laboratories using different testing apparatus may differ in the diagnosis of identical conditions. Monochromats may be subdivided according to the type of photoreceptor(s) they retain. The distinction between some forms of monochromatism is unclear, and clarification will have to await the discovery of the underlying genetic mutations. the rod monochromat can detect only brightness differences, and is therefore truly colour-blind? Patients with this disorder usually present in early infancy with nystagmus, marked photophobia and reduced acuity. The nystagmus is typically of rapid frequency and low amplitude. In many cases, the nystagmus decreases in severity by the end of the first decade. Commonly, there is a high hypermetropic refractive error. In affected individuals who are old enough for accurate assessment, the visual acuity is usually about 6/60 when assessed using a standard letter chart at photopic illumination levels. Fig. 2 . The e/ectroretinograms of a normal control subject (left) and a rod monochromat aged 11 years (right! using gold foil recording electrodes.
The rod responses are normal, but there are no recordable cone responses.
Histopathological investigation of donor eyes from subjects with rod monochromatism has demonstrated the presence of cone-like structures in the retinaY-14 However, the studies have given conflicting reports as to the nature and distribution of these cones. Larsenll found that the cones had short outer segments with large diameters, especially around the macular area. Harrison and colleagues12 reported that the cones were abnormally shaped and reduced in number throughout the entire retina. Falls and colleagues13 found cone numbers at the fovea to be normal, but their shape to be abnormal. In the periphery the cones were scarce, though less commonly malformed. In contrast Glickstein and Heath14 found that the fovea was totally devoid of cones; those present in the surrounding area were abnormal in morphology.
Psychophysical testing may also reveal residual cone function in rod monochromats. For example, a Stiles-Crawford effect may be demonstrated,15 and the dark adaptation curve may be biphasic. [15] [16] [17] [18] [19] Increment threshold experiments may also show a duplex function?0,21 In an extensive survey of the psychophysical literature, Sharpe and Nordby8 report that 18 out of a total of 37 investigations of rod monochromatism claim to have found psychophysical evidence of cone function. In addition, Krastel and Jaege?2 have demonstrated, using large fields, that many of those labelled as rod monochromats may have residual cone function. However, many of the studies should be treated with caution: it is possible that the investigators were describing occult cases of incomplete achromatopsia, or even progressive cone dystrophy. 8 The genetic mutation responsible for rod monochromatism has not been identified, but Arbour et al. 23 have demonstrated linkage of the disorder in a large Iranian Jewish pedigree to a 30 cM region spanning the centromere of chromosome 2. Rod monochromacy has also been reported to occur in association with isodisomy of chromosome 14.24 Carriers of rod monochromatism are generally considered to possess normal visual function. However, it has been claimed that some carriers display subtle colour vision abnormalities?5,26
Autosomal recessive incomplete achromatopsia
As stated previously, the term 'incomplete achromatopsia' is a misnomer. This condition is also sometimes called atypical achromatopsia. The 'incomplete achromat' appears to have residual colour discrimination.27 However, in many ways this condition resembles rod monochromacy. Affected individuals may have slightly better visual acuity than the rod monochromat (6/24-6/60), poor colour discrimination, nystagmus, photophobia and an absent cone electroretinogram? However, when tested using large field sizes at appropriate illumination levels (so that rod participation is possible), these patients display crude dichromacy or even trichromacy. 
Blue cone monochromatism
The blue cone monochromat possesses a normal rod system with a normal S-cone mechanism. Blue cone monochromatism is an X-linked recessive disorder, and affected males present with reduced acuity (6/24-6/60), nystagmus and photophobia? The condition is also sometimes known as X-linked atypical achromatopsia or 'TTl monochromacy. Most affected individuals are myopic; fundus examination may show tilted optic discs though the macular appearance is normal (Fig. 3) . Using standard ERG protocols, the abnormalities are similar to those seen in rod monochromacy (Fig. 4) responses37,41 and mild abnormalities of colour vision;9 they may also show abnormalities on eye movement recording. 42 Nathans and his colleagues43 were the first to investigate in detail the molecular genetics of blue cone monochromatism. The defects in their patients could be divided into two distinct subtypes. In the first, there is a two-step mechanism: the L-and M-cone photopigment array is reduced to a single gene by unequal homologous recombination; a further mutation renders the remaining gene defective. In one of the original 12 families studied, there was a remaining L-cone photopigment gene, and in another three there was a 5' L-3' M hybrid gene. Cloning of the hybrid genes revealed a cysteine to arginine mutation at codon 203. This mutation is known to disrupt the folding and half-life of M-cone opsin molecules. 44 The second mechanism consists of a non homologous deletion of genetic material upstream of, and sometimes including, the pigment gene array. The deletion sizes ranged from 587 bp to 55 kb. All the deletions included the 587 bp region missing in patients with the smallest deletion. This region lies 3 kb upstream of the opsin gene array, and is believed to act as transcriptional control element. The region is commonly referred to as the locus control region (LCR). In a second study of the condition, Nathans et al. 45 reported further genetic heterogeneity in the condition. This study includes one family in which there are two photopigment genes containing mutations in codon 203. 45 Reyniers et al. 46 have reported a pedigree with a similar genetic defect. Recently, a pedigree has been reported where affected patients have one L-cone photopigment gene in which ex on 4 is deleted. 47 It appears there may be some degree of overlap between blue cone monochromacy and X-linked progressive cone dystrophy (see below). For example, Nathans et al. 43 reported a subject in which a very slow degeneration is apparent, and Nathans et al. 45 reported the molecular genetic findings of a family previously described in a paper by Fleischman and O'Donnell.48 This family appeared to display a progressive dystrophy; older members of the pedigree demonstrated achromatopsia with severely reduced acuity, whereas younger members had markedly lower FM 100-Hue scores together with better acuity; the older patients also showed noticeable fundus changes. These patients also had mildly reduced scotopic electroretinographic responses. Previous reports by Blackwell and Blackwell18 and Francois et al. 49 had hinted at the possibility that blue cone monochromacy may progress to resemble rod monochromacy. Interestingly, the pedigree described by Francois et al. 49 is the same as the family in the molecular genetic study of the condition by Reyniers et al.
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Although it appears that in the majority of families the condition is stationary, there is convincing evidence to suggest that progression does occur in other pedigrees. The pedigree described by Fleischman and O'Donne1l48 would certainly be better described as having a progressive cone dystrophy.
Achromatopsia with normal visual acuity
Achromatopsia with normal visual acuity is extremely rare, affecting approximately 1 in every 100 million people.50 Affected individuals are monochromats, though they have normal visual acuity, and it appears that these conditions are not purely receptoral; therefore, strictly speaking these conditions are not cone dystrophies. Alpern58 has reported a case of monochromacy with normal visual acuity in which the subject displayed monochromacy and a normal luminosity function in combination with normal acuity. This type of achromatopsia has been referred to as the' deuteranopic form,.s7 Reflectometry revealed that there was only one cone visual pigment in the 'red-green range', though a 'lT1 function could be demonstrated, indicating that there was a combination of a photopigment and a post receptoral defect.
Cases of monochromacy with normal visual acuity have been reported in pedigrees carrying multiple forms of colour vision deficiency; CroneS9 reported a pedigree in which tritan and deutan defects occur. Whilst two patients were believed to have achromatopsia, two also appeared to have what Crone described as 'colour amblyopia'. These patients had normal acuity but very poor colour discrimination. WealeS1 reported that one of his monochromats, J.G., had a protanomalous father and a prot anomalous son.
Oligocone trichromacy
Oligocone trichromacy is a stationary cone dystrophy first recognised by van Lith60 in which the affected patient displays reduced visual acuity, a reduced photopic electroretinogram and a normal fundus appearance. However, these patients are trichromats60 and they may show good colour discrimination. Reflection densitometry reveals that there is a decreased photo pigment concentration, though regeneration rates appear to be normal.61 It has been proposed that oligocone trichromacy results from a reduced cone population for all cone types.62 What remains unclear is whether these patients should be grouped with incomplete achromats: for example one of the patients investigated by Pokorny and colleagues27 in their study of autosomal recessive incomplete achromatopsia had previously been classified as having oligo cone trichromacy.
Progressive cone dystrophies
The progressive cone dystrophies are a genetically heterogeneous group of disorders characterised by early deterioration of visual acuity and colour vision. Other clinical features include photophobia, nystagmus and visual field abnormalities. Visual field defects include central scotomata,9,63 peripheral field loss,9 generalised depression of sensitivity63,64 and ring scotomata.6S (Fig. 5) dystrophies. These techniques are most useful in investigating large families with many affected individuals (when a specific pattern of disease can be seen to segregate clearly with the genetic mutation). Such techniques are also most informative in subjects with early or mild disease; in advanced disease, any differences between different phenotypes are usually unrecognisable due to the severe photoreceptor dysfunction.
Colour vision
A variety of colour vision deficiencies occur in progressive cone dystrophies. These include protanopia,69,70 protanomaly, pseudoprotanomaly/l type II acquired67' and tritan defects?3-76 Pokorny et al. so suggested a classification of progressive cone dystrophy based upon colour vision. Three groups could be differentiated, as described below:
Cone dystrophy and type I acquired red-green defect These patients have both a progressive cone dystrophy and evidence of pseudoprotanomaly.5o Pseudoprotanomaly is diagnosed when a subject requires more red in the red-green mixture when performing a Rayleigh match than is required by a normal observer, though brightness matches are normal. This form of colour vision defect is thought to be the result of a reduction in the effective optical density of the photopigment, be it through photoreceptor tilt or decreased concentration of the photopigment.5o In the late stages of the condition, scotopisation is observed (where visual function is dominated by the rod system).
Cone dystrophy without type I acquired red-green defect
Patients with abnormal photopic ERGs may appear to have no significant impairment in colour vision, or only a very slight tritan defect.
Type I acquired red-green defect without cone dysfunction In some patients with all the signs and symptoms of progressive cone dystrophy, there may be a pronounced type I acquired colour vision deficiency in the absence of an abnormal photopic electroretinogram. Such patients are usually said to suffer from a central cone dystrophy.
Unfortunately, some cone dystrophies will not be easily categorised into one of the above groups. For example, pedigrees with classical tritan defects have 'Verriest 72 has classified acquired colour vision deficiencies into three groups. A type I acquired colour vision deficiency is characterised by a red-green defect with a reduction in visual acuity. This type of defect is also accompanied by an alteration in relative spectral sensitivity, which eventually becomes scotopic (so-called scotopisation). A type II acquired colour vision deficiency is a red-green defect that is often combined with a milder tritan defect; the luminosity curve is usually normal. A type III defiCiency is a tritan defect in which the luminosity curve may be normal or abnormal.
been reported?3-76 In addition, patients suffering from cone dystrophy without type I acquired defect could appear to have a colour vision deficiency if colour visual fields were assessed; similarly, those exhibiting type I acquired defect without cone dysfunction might be expected to display electroretinographic abnormalities if focal electroretinograms were performed.
Other psychophysical testing
Scotopic and photopic perimetryt have been used (often in combination with electrophysiological testing) to identify particular patterns of disease.77-81 Using such techniques it is possible to distinguish those individuals with a pure cone dystrophy from those with a concomitant rod involvement; the latter, as expected, have a poorer visual prognosis. A further dichotomy is revealed by such testing: in some patients there is regional loss of cone function, whereas in others there is a diffuse loss of cone function?8--S0 Szlyk et al. 80 have proposed a classification of progressive cone-rod dystrophy based upon electroretinography and perimetry. One may distinguish those dystrophies that cause a marked reduction of photopic function with little effect on the scotopic function from those that affect both systems markedly (types one and two respectively). A further subdivision is provided by perimetry: in type ' a' there are central field defects whilst in type 'b' there is predominantly peripheral visual field loss. Yagasaki and Jacobsen77 have used scotopic static perimetry to define three patterns of cone and rod dysfunction. These patterns show some overlap with the classification of Szlyk et al.
Although different test protocols have been used in the different psychophysical studies, it does appear that progressive cone dystrophies may be divided into those that result in abnormal cone function without rod involvement and those with evidence of dysfunction of both types of receptor. Both subgroups can be further subdivided on the basis of whether there is predominantly central cone involvement or diffuse elevation of cone thresholds throughout the retina. There is also some evidence to suggest that there is a significant post-receptoral defect in some families.82•s3
Electroretinography
In some respects, electroretinographic classification corresponds to that obtained via visual field analysis. Most individuals with progressive cone dystrophy show severely reduced cone responses with preserved rod function (at least in the early stages). However, some tScotopic and photopic perimetry are also often termed 'rod-' and 'cone-' perimetry respectively. Scotopic perimetry usually involves standard static perimetry protocols, though the patient is dark-adapted. Large (Goldman size V) short wavelength targets are typically used. Photopic perimetry requires a background set to photopic levels (typically 10 cd /m 2 ). The stimuli are usually of long wavelength. patients appear to display normal or near normal electroretinograms in the presence of all the other signs and symptoms of cone dystrophy. Such patients are said to suffer from a peripheral cone dystrophy. A minority of patients show other distinct electroretinographic abnormalities that may help identify subgroups with a specific underlying pathology. For example, a small subgroup of patients with cone dystrophy may show supra normal scotopic responses.84,S5 Fujii et al. 86 have described a family with autosomal dominant cone-rod dystrophy in which the earliest abnormality was a 'negative wave' configuration, suggesting that there is significant inner retinal dysfunction. Kellner et al.H7 have also described cone dystrophy patients with negative electroretinograms.
Mode of inheritance
The most straightforward way of classifying the progressive cone dystrophies is by the inheritance pattern; there is, however, considerable heterogeneity even within each genetic subtype. A summary of the known loci for progressive and stationary cone dystrophies is given in Table 1 . It is unclear how many different genetic mutations cause cone dystrophy.
X-linked recessive progressive cone dystrophy X-linked cone dystrophy is uncommon, though several well-documented families have been reported.4R,63,67,6�,7J,88-9J It is evident from the clinical descriptions of these families that, although the earliest symptoms and signs are related to cone dysfunction, there is rod dysfunction late in the disease; therefore these disorders are more correctly classified as cone-rod dystrophies. Affected males are often myopic, and usually present with subnormal acuity and colour vision deficiency. A tapetum-like sheen that diminishes with dark adaptation (the so-called Mizuo phenomenon) has been reported in affected males from some families.63,67 The majority of carriers also showed reduced cone photopigment density on foveal densitometry. X-linked progressive cone dystrophy has been mapped using genetic linkage studies to three loci: Xp21-pIl.l (CODl),88 Xq27 (COD2)91 and to Xq28 (not assigned).69 Although few families are available for comparison, there are clear differences in the phenotypes of families mapping to the diferent loci. Reichel et al.
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have described a pedigree in which progressive cone dystrophy is accompanied by a protanopic colour vision deficiency. Molecular analysis of the L-cone photo pigment revealed a 6.5 kb deletion. More recently, Kellner et al. 70 reported two patients with no family history of cone dystrophy. The patients, like those of Reichel, displayed a protan colour vision deficiency; screening of the photo pigment array revealed that one patient had only one L-M hybrid gene, whilst the other had both an L-M hybrid gene and a normal M pigment gene. Such genetic alterations usually result in congenital colour vision deficiency.6,70 Why such a genotype might give rise to a progressive cone dystrophy remains unclear. It should also be added that Kellner et al. could not rule out the possibility that the patients they investigated were protans who happened to develop a progressive cone dystrophy. Meire et al.88 reported linkage to Xp2I-I1.I (CODI) in the pedigree they investigated. Affected patients were myopic, had impaired colour vision leading to achromatopsia in older subjects, progressively impaired visual acuity and abnormal photopic electroretinograms. The electro-oculogram was also abnormal. Visual field Mutations of other genes responsible for CRD remain to be discovered. These will be identified either by initial linkage studies in large families, followed by analysis of candidate genes mapping to the same loci, or by the study of genes which seem to be good candidates based upon careful investigation of the phenotype in smaller families.
Autosomal reccssil'c coile dystrophy There is as yet no specific treatment for any of the cone dystrophies. However, it is very important that the correct diagnosis is made so that affected individuals and their parents can be offered genetic counselling, including accurate information about the long-term visual prognosis. The diagnosis of an inherited retinal dystrophy in one member of a family may have implications for other asymptomatic family members, particularly for females in X-linked pedigrees, and counselling may need to involve the wider family. In some families where the genetic mutation is known or the disorder has been closely mapped, molecular genetic diagnosis may be possible in cases where there is doubt about the genetic status of an individual.
Patients with poor central vision should be referred for assessment for low visual aids and, where appropriate, for advice about help with their education. Adults and children with severe photophobia may be helped by tinted spectacles or contact lenses. The tints used depend on the type of dystrophy. For example, the rod monochromat is best served by using a deep red tint;114 this allows wavelengths of low luminous efficiency for the rod system to be transmitted to the eye, whilst those that have a higher luminous efficiency are absorbed by the filter. This results in a reduction in both disability and discomfort glare. Naturally, such lenses alter the relative spectral sensitivity function of the patient, so that they will report that red no longer appears so very dark. Recently that blue cone monochromats benefit most from magenta tints.11S Patients with progressive cone dystrophy may also be aided by tinted lenses. 1 1 6 The tint will depend on the dystrophy's effect on visual function: some patients, for example those with well-preserved colour vision and cone function, may be best served by neutral tints; others in the end stages of the disease may benefit from deep red tints in the same way as rod monochromats. Some caution should be exercised when fitting cone dystrophy patients with contact lenses. Because colour vision is poor (or absent), patients may be incapable of detecting conjunctival erythema by themselves. Additionally, the symptoms of some contact lens complications, such as photophobia resulting from corneal infiltration, could be masked by the symptoms of the dystrophy. Miotic drops may be used by patients with severe photophobia, but are rarely well tolerated.
Conclusion
The cone and cone-rod dystrophies comprise a heterogeneous group of disorders, each differing in their clinical features, underlying genetic mutation and visual prognosis. Great progress has been made in recent years in the understanding of the disease mechanisms underlying the cone dystrophies and it is likely that rapid advances in our knowledge of the progressive cone dystrophies in particular will develop, especially as the causative genetic mutations are identified. Previous research has concentrated on defining and classifying the clinical phenotype in order to guide the search for genetic mutations. The future emphaSiS will shift, as more genes responsible for causing cone dystrophy are identified, towards exploring the effects on retinal function of specific genetic mutations in human and experimental animal models. This will necessitate a collaboration between clinicians and scientists working in a variety of different diSciplines, including molecular genetics, cell biology, psychophysics, electrophysiology and developmental biology. The real challenge remains in the identification and implementation of treatment methods that will improve or stabilise retinal function and prevent blindness.
